Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSite revision updated to v3.5.2; v3.5.0 was removed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Type 2 diabetes as a related topic and included MedlinePlus Genetics as related topics. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check43 days agoChange DetectedRemoved related topics tags: 'Type 2 diabetes' and 'MedlinePlus Genetics' from the study page.SummaryDifference0.2%

- Check50 days agoChange DetectedRevision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now shows Revision: v3.4.2; the prior government-funding lapse notice and the Revision: v3.4.1 entry were removed.SummaryDifference0.4%

- Check86 days agoChange DetectedNotice: Added a government funding lapse banner and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.